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Abstract
Background—Young African-American women have the highest rates of Chlamydia
trachomatis and Neisseria gonorrhoeae in the United States. The objective was to identify baseline
predictors of repeat Chlamydia and/or gonorrhoea infections among African-American adolescent
females.
Methods—Sociodemographic, psychosocial and behavioural data were collected at baseline and
every 6 months for 2 years from 701 African-American females (14–20 years) enrolled in an HIV
prevention trial. Vaginal swabs were self-collected at each visit and assayed for Chlamydia and
gonorrhoea using DNA amplification. Among participants testing positive for Chlamydia and/or
gonorrhoea at baseline, logistic regression analyses assessed baseline predictors of repeat
infection.
Results—Of 618 (88%) participants with ≥1 follow-up assessment, 123 (20%) had a positive
Chlamydia and/or gonorrhoea test result at baseline; 49 (40%) had a repeat infection during the
study period. Of those with a repeat infection, 30 (61%) were positive at one follow-up visit, 18
(37%) at two and 1 (2%) at three follow-up visits. Controlling for age and intervention condition,
impulsivity (AOR: 1.71, p=.018) was associated with an increased likelihood and having a
boyfriend (AOR: 0.21, p=.006) a decreased likelihood of repeat infection.
Conclusions—Repeat Chlamydia and/or gonorrhoea infections are common among African-
American adolescent females. Among young African-American women who test positive for
Chlamydia and/or gonorrhoea, tailored interventions for more impulsive adolescents and those not
in a relationship may reduce risk of repeat infections. Given high numbers of repeat infections
after receipt of an evidence-based intervention, enhanced screening and treatment services for
young men may be warranted.
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Introduction
In the United States, Black females 15–19 years of age have the highest rates of both
Chlamydia trachomatis and Neisseria gonorrhoeae among all age, race/ethnicity and gender
categories.1 Figures 1 and 2 present the rates of Chlamydia and gonorrhoea, respectively,
among females 15–19 years in the United States in 2010, by race/ ethnicity.1 Studies have
estimated that up to 53% of all Chlamydia diagnoses are repeated infections and persons
with repeat infections account for up to 48% of gonorrhoea diagnoses.2,3
Both Chlamydia and gonorrhoea are associated with adverse reproductive health outcomes
such as pelvic inflammatory disease, infertility, ectopic pregnancy and perinatal infections.4
Reinfection is associated with increased risk of adverse reproductive health outcomes.4 Both
Chlamydia and gonorrhoea also facilitate human immunodeficiency virus (HIV)
transmission.5 The annual direct medical costs of treating sexually transmitted infections
(STIs), excluding HIV, and their sequelae is $8 billion.6 The time of diagnosis may be an
important opportunity to prevent subsequent infections.2 Examining factors that predict
repeat infection may help researchers and programmers develop and target interventions to
reduce infection rates and their public health burden.
Individual and partner behaviour and relationship and psychosocial factors influence STI
risk. Individuals who have been adequately treated for Chlamydia and/or gonorrhoea may
become reinfected through a new infected partner or an existing partner who has not been
adequately treated or has a newly acquired infection. Partner-level factors associated with
STIs among adolescent females include older partner age, a partner with concurrent sexual
partners, sex with a high or drunk partner and a partner recently released from
incarceration.7–10 Psychosocial factors, such as stress and depression, are associated with
increased sexual risk behaviour among adolescents.11 Among African-American adolescent
females, heavy alcohol use has been shown to predict STI acquisition and sexual risk
behaviour, including inconsistent condom use, multiple sexual partners and sex while high
or drunk.12 Abuse and dating violence also impact STI risk. Evidence shows that African-
American young women who experienced sexual violence as youth have increased risk for
STIs, earlier sexual debut and a greater number of lifetime sex partners.13,14 Among
adolescents, dating violence is associated with increased sexual risk behaviour and
substance use.15 Adolescents who experience dating violence may be at increased risk of
STIs through forced sex or reduced capacity negotiate to safer sex practices.13,15,16 Among
African-American adolescent females, a history of dating violence is associated with
increased fear about the consequences of condom negotiation and fear of talking to a partner
about pregnancy prevention.16
Despite marked disparities in the rates of Chlamydia and gonorrhoea, we are not aware of
studies that have explored predictors of repeat infection exclusively among young African-
American females. The objective of this study was to identify baseline predictors of repeat
Chlamydia and/or gonorrhoea infections among African-American adolescent females
enrolled in an HIV prevention trial who tested positive for Chlamydia and/or gonorrhoea at
baseline.
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From July, 2005, to June, 2007, African-American adolescent females were recruited from
three reproductive health clinics in Atlanta, GA, to participate in an HIV prevention trial.
Potential participants were approached in clinic waiting areas by a female African-American
recruiter who assessed study eligibility. Eligibility criteria included age 14–20 years and at
least one episode vaginal sex without a condom in the past 6 months. Individuals who were
married, pregnant or attempting to become pregnant were excluded from participating. On a
return visit to the clinic, written informed consent was obtained with parental consent
waived for individuals younger than 18 years. Participants then completed baseline
assessments and were randomized to trial conditions. Of 1,684 individuals screened, 745
met eligibility criteria. Of eligible adolescents, 94% (N=701) enrolled and were randomized
(intervention condition n=342; comparison condition n=359). Participants were
compensated $75 for travel and childcare to attend intervention sessions and complete
assessments. This analysis reports on 618 (88%) participants who, in addition to the baseline
assessment, completed ≥1 assessment during two years of follow-up post-intervention. The
Emory University Institutional Review Board approved all study protocols.
Study procedures
The parent study was a randomized controlled supplemental treatment trial. As such, all
participants received the same “primary” treatment, and, depending on study condition,
received one of two supplemental treatments. The purpose of the trial was to assess whether
supplemental treatment could enhance maintenance of an efficacious HIV risk reduction
intervention.17 All participants received a single 5-hour, group-delivered HIV risk reduction
intervention based on HORIZONS, a two-session intervention shown to be efficacious
among African-American females.18 Participants assigned to the intervention condition then
received 12 brief phone calls during which a health educator conducted an HIV risk
assessment and provided individualized HIV prevention counseling. Participants assigned to
the control condition also received 12 brief phone calls, but the health educator conducted a
nutritional risk assessment and provided nutrition counseling. Participants received calls
approximately every 8 weeks for 24 months following the primary treatment.
Data collection occurred at baseline and 6-, 12-, 18- and 24-months post-intervention and
consisted of an audio computer-assisted self-interview (ACASI) and a self-collected vaginal
swab. The ACASI assessed sociodemographics, sexual history and psychosocial constructs
associated with sexual risk behaviours. After completing the ACASI, participants provided a
self-collected vaginal swab that was assayed for Chlamydia and gonorrhoea, using the
BDProbeTec ET Chlamydia trachomatis and Neisseria gonorrhoeae Amplified DNA Assays
(Becton Dickinson and Company, Sparks, MD).19 Participants with a positive STI test result
received directly observed single-dose antimicrobial treatment and risk-reduction counseling
per Centers for Disease Control and Prevention recommendations and were encouraged to
refer sex partners for treatment. The County Health Department was notified of reportable
STIs.
Summary of main trial findings
There were no differences between study conditions in terms of sociodemographic
characteristics, STIs or behavioural outcomes at the time of randomization. Retention was
similar with 89.2% of individuals in the intervention condition and 87.2% in the comparison
condition completing ≥1 follow-up assessments (p=0.414). There were statistically
significant differences in the primary and secondary outcomes between the two arms
through 18 months. Participants in the intervention arm had a lower proportion of incident
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Chlamydia infections (7.0% vs. 13.6%, p=0.009), lower mean frequency of sex while high
on drugs or alcohol (1.42 vs. 2.42; p=0.009) and higher mean percent condom-protected sex
acts (58% vs. 52%; p=0.049).17
Measures
Repeat infection was defined as a positive Chlamydia and/or gonorrhoea test following a
negative result or documented treatment, among individuals positive for Chlamydia and/or
gonorrhoea at baseline.
Sociodemographic factors considered as potential baseline predictors included age (years)
and having a paid job (yes/no). Family aid was assessed with a 4-item index. Participants
respond yes/no to “In the past 12 months, did you or anyone you live with receive any
money or services from”: a) “Welfare (including TANF (Temporary Assistance to Needy
Families) or SSI)?”; b) “food stamps?”; c) “WIC (Women, Infants and Children?” and d)
“Section 8 housing (housing subsidies)?”.
Cigarette smoking and substance use—Smoking was assessed with the question “Do
you smoke cigarettes?” (yes/no). Alcohol use in the 90 days prior to baseline assessment
was assessed with “In the past 90 days, how many days have you used alcohol?” and “How
many alcoholic drinks do you usually have at one time?” Participants who indicated they
used alcohol on ≥1 days were categorized as users. Participants who indicated they usually
had ≥3 drinks on one occasion were categorized as heavy alcohol users. Marijuana use prior
to baseline assessment was assessed with “In the past 90 days, how many days have you
used marijuana?” Participants were dichotomized as having or not having used marijuana.
Sexual risk behaviours assessed at baseline included: age at first sex (years), lifetime
number of vaginal sex partners (above or equal to the median number vs. less than median)
and self-reported STI history (yes/no). Sexual behaviours in the 90 days prior to baseline
assessment included: a) number of vaginal sex partners; b) percent condom use during
vaginal sex, calculated by dividing the number of times the respondent had vaginal sex by
the number of times condoms were used; c) consistent condom use, defined as 100% use
during vaginal sex (yes/no). We also assessed the participant’s report of being drunk or high
during sex (yes/no) as a potential baseline predictor. Participants’ responses were
dichotomized based on the question “In the past 90 days, how many times did you have sex
while high on alcohol or drugs?”; reports of ≥1 times were categorized as engaging in the
behaviour. In addition, we explored whether hormonal contraceptive use (“pills/ patch/
depo”) at last sex (yes/no) predicted repeat infection.
Partner-level factors included: a) currently having a boyfriend (yes/no); b) participant’s
perception of whether her current boyfriend had sex with another woman during the
relationship (yes/no); c) currently having a casual partner (yes/no); d) general age of partners
(≥2 years older vs. same age or younger) and e) sex in the past 6 months with a male partner
recently released from jail, prison or detention (yes/no) and f) sex with a partner who was
high or drunk during sex in the past 90 days (yes/no). Participants were asked “In the past 90
days, how many times did you have sex while your partner was high on alcohol or drugs?”;
reports of ≥1 times were categorized as engaging in the behaviour.
Psychosocial Constructs Associated with Sexual Risk Behaviour included perceived
interpersonal stress, depressive symptomology, fear of condom negotiation, partner
communication self-efficacy, impulsivity and sexual sensation-seeking. Perceived stress was
assessed with a 14-item scale, in which respondents indicated their level of stress around
various interpersonal situations and their overall stress level from 1= no stress to 5=extreme
stress; a sample item was, “relationships with family members” (α=0.88). Depression was
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measured with an 8-item scale (α=0.90);20 participants were asked how frequently during
the past week they experienced depressive symptoms from 1=less than one day to 4= 5–7
days. A sample item was “I felt sad”. Participants with a score of 16 or greater were
classified as having elevated depressive symptoms. Fear of consequences of condom
negotiation was measured using a 7-item scale (α=0.88); a sample item was “I have been
worried that if I talked about using condoms with my boyfriend or sex partner he would
threaten to leave me”. Participants responded from 1=never to 5=always. Partner
communication self-efficacy was assessed with a 6-item index (α=0.82); a sample item was,
“How hard is it for you to demand that he use a condom?” Participants responded from
1=very hard to 4=very easy. Impulsivity was measured with a 15-item scale (α=0.82);21 a
sample item was “I just react without thinking.” Participants responded from 1=never to
5=always. A 10-item scale measured sexual sensation-seeking (α=0.74). The original 9-item
scale was modified to include “Videotaping or photographing myself and my partner having
sex is exciting”.22 Participants responded from 1=strongly disagree to 4=strongly agree.
With the exception of depressive symptomology, all psychosocial measures used in
regression models were standardized to mean zero and unit variance.
History of abuse—A history of emotional abuse was assessed with “Have you ever been
emotionally abused? (threatened, called names, etc.)” (yes/no). Physical abuse was assessed
with “Have you ever been physically abused? (hit, punched, kicked, slapped, etc.)” (yes/no).
Sexual abuse was assessed with “Has anyone ever forced you to have vaginal sex when you
didn’t want to?” (yes/no).
Data analysis
T-tests and chi-square statistics compared selected baseline characteristics among study
participants according to completion of at least one post-intervention assessment.
Descriptive statistics assessed the frequencies of repeat infections. Simple and multivariable
logistic regression analyses identified baseline factors associated with repeat infection
during the 2-year follow-up period among participants positive for Chlamydia and/or
gonorrhoea at baseline. Thus, the comparator groups are individuals positive for 1 or both
STIs at baseline and at a subsequent visit and individuals positive for 1 or both STIs at
baseline only. First, simple logistic models assessed associations between potential baseline
predictors and repeat infection. Factors significant at p<0.1 were entered together into a
multivariable model, controlling for age and treatment assignment.
Results
Sample characteristics
Table 1 compares selected baseline characteristics among study participants according to
their completion of at least one post-intervention assessment. Participants excluded from
analysis because they only completed the baseline assessment were more likely to smoke
(27.7% vs. 14.9%, p=0.003), use alcohol heavily (21.7% vs. 9.9%, p=0.001), report being
high or drunk during sex in the past 90 day (39.8% vs. 26.5%, p=0.012) and experience
sexual abuse (36.1% vs. 22.3%, p=0.006). They also reported a greater proportion of
protected sex acts in the past 90 days (38.2% vs. 36.9%, p=0.023). Of participants who
completed ≥1 post-intervention assessment (n=618), 19.9% (n=123) had a laboratory-
confirmed diagnosis of Chlamydia and/or gonorrhoea at baseline; 16.5% were positive for
Chlamydia, 6.5% were positive for gonorrhoea and 3.1% were positive for both Chlamydia
and gonorrhoea.
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Frequency of repeat infections
Forty-nine participants (intervention condition n=30; comparison condition n=19) who were
positive for Chlamydia and/or gonorrhoea at baseline had a repeat infection during the study
period (40.0%). Of those with a repeat infection, 30 (61.2%) were positive at a single
follow-up visit, 18 (36.7%) at two visits and one (2.0%) at three total follow-up visits.
Baseline predictors of repeat infection
Table 2 presents unadjusted and adjusted associations between potential baseline predictors
and repeat Chlamydia and/or gonorrhoea infection among 123 participants positive for at
least one of these infections at baseline. In both unadjusted and adjusted models, greater
impulsivity (AOR: 1.69, 95% CI: 1.08, 2.65, p=0.021) predicted an increased likelihood of
repeat infection and having a boyfriend (AOR: 0.21, 95% CI: 0.07, 0.62, p=0.005) predicted
a decreased likelihood of repeat infection.
Conclusions
Repeat Chlamydia and/or gonorrhoea infections were common among African-American
adolescent females in this study; 40% who were positive at baseline experienced a repeat
infection within two years of the intervention. Other studies among adolescents in the
United States with a follow-up period of at least 20 months have reported Chlamydia
reinfection estimates from 18.0% to 23.3%.4 Gonorrhoea reinfection estimates of up to 40%
within 20 months of follow-up have also been reported.4 Fortenberry et al found 41.1% of
adolescent girls positive for gonorrhoea, Chlamydia and/or trichomonas experienced a
subsequent infection within 12 months.23 The high proportion of repeat infection in this
study may suggest a reservoir of infection among asymptomatic males. Given that all
participants received an evidence-based intervention as the primary treatment, enhanced
screening and treatment efforts for young men may be warranted.
Greater impulsivity predicted repeat infection. Research suggests that individuals with poor
impulse control may be more likely to engage in risky sexual behaviours or have sex with
risky partners;24,25 however, to our knowledge, impulsivity has not previously been
identified as a factor related to repeat Chlamydia or gonorrhoea infections. Interestingly,
sexual sensation-seeking, often related to impulsivity and sexual risk behaviours,22,24,25 was
unrelated to repeat infection. Although impulsivity and sensation seeking are related, and
usually moderately correlated, they represent unique traits. The ability to differentiate
between the two and understand how they independently relate to repeat infection is
important when considering strategies to reduce repeat infections.
Having a boyfriend predicted a decreased likelihood of repeat infection. Increased risk of
repeat Chlamydia and/or gonorrhoea infection among individuals without a boyfriend could
have been due to an increased likelihood to obtain a new partner or of continued sex with an
untreated partner. Among a sample of women at least 15 years of age, Niccolai et al found
the population attributable risk of recurrent Chlamydia infections was similar for sex with a
new sex partner and sex with a partner not known to be treated.26
Strengths and Limitations
This study is subject to a number of limitations. Some of the factors assessed were subject to
change over time, and some were targeted by the intervention. In addition, the intervention
was effective in reducing incident STIs. Despite these limitations, many types of potential
factors were assessed, and two significant baseline predictors of repeat Chlamydia and/or
gonorrhoea infection were identified. It is also possible that participants may have been
diagnosed and treated between study visits or after the study ended. These findings are
Swartzendruber et al. Page 6













relevant only to the two years of follow-up post-intervention and could be subject to error to
the degrees that participants were diagnosed and treated between study visits and their
baseline characteristics varied from those who were not. The study did not achieve 100%
retention, therefore the proportion of participants who were categorized as experiencing a
repeat infection may be over- or underestimated. Participants excluded from this analysis
because they did not return for follow-up assessment were more likely to report heavy
alcohol use, being high or drunk during sex and sexual abuse, which increase the likelihood
of STI acquisition, and they were only slightly more likely to use condoms; therefore, our
findings might underestimate repeat infections. Nevertheless, particular strengths of this
study are its duration of assessment and high retention rate. The number of cases available
limited the ability to assess baseline predictors of repeated Chlamydia and gonorrhoea
infections separately. However, assessing these infections together is consistent with a
public health approach in that both infections are prevalent in this population, are
transmitted by unprotected sex with an infected partner and cause adverse reproductive
health outcomes. Lastly, the possibility exists that treatment failures were misclassified as
repeat infections; therefore, the findings may overestimate repeat infections and the strength
of the relationship between the baseline predictors and repeat infection may be
underestimated.
Implications
These results confirm the need to rescreen young women diagnosed with Chlamydia or
gonorrhoea. The findings suggest that individual baseline factors influence repeat infection
despite receipt of an efficacious intervention. Among young African-American females who
test positive for Chlamydia and/or gonorrhoea, assessing impulsivity and relationship status
may allow for tailored interventions to help prevent repeat infections. For example, more
impulsive adolescents may benefit by learning about the role of impulsivity and its potential
impact on sexual decision-making as well as how to identify and utilize strategies to avoid
situations where they are likely to behave impulsively. In addition, enhanced STI screening
and treatment efforts among young men may be warranted, given the limitations of current
interventions for female adolescents to adequately reduce the number of repeat infections.
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• Among African-American adolescent females, repeat Chlamydia trachomatis
and/or Neisseria gonorrhoeae infections were common.
• Greater impulsivity and not having a boyfriend at baseline predicted repeat
infection during two years of follow-up.
• Tailored interventions for more impulsive adolescents and those not in a steady
relationship may reduce risk of repeat infections.
• Given high numbers of repeat infections after receipt of an evidence-based
intervention, enhanced screening and treatment services for young men may
also be warranted.
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Rate of Chlamydia per 100,000 population among females 15–19 years, by race/ethnicity,
United States, 20101
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Rate of gonorrhea per 100,000 population among females 15–19 years, by race/ethnicity,
United States, 20101
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Table 1
Selected baseline characteristics among African-American females 14–20 years of age participating in an HIV
prevention trial according to their completion of at least one post-intervention assessment
Variable
At least one post-intervention
assessment (n=618)




Age (years), mean (SD) 17.6 (1.7) 17.8 (1.5) 0.296
Paid job 231 (37.4) 24 (28.9) 0.132
Family aid index, mean (SD) 0.9 (1.0) 0.7 (1.0) 0.216
Current cigarette smoking and substance use in past 90 days
Smoking 92 (14.9) 23 (27.7) 0.003
Alcohol 318 (51.1) 46 (55.4) 0.463
Heavy alcohol 61 (9.9) 18 (21.7) 0.001
Marijuana 238 (38.5) 36 (43.4) 0.394
STIs diagnosed at baseline
Chlamydia 102 (16.5) 18 (21.7) 0.239
Gonorrhea 40 (6.5) 4 (4.8) 0.560
Chlamydia and gonorrhea 19 (3.1) 1 (1.2) 0.337
Chlamydia and/or gonorrhea 123 (19.9) 21 (25.3) 0.253
Lifetime sexual history
Age at first sex (years), mean (SD) 14.8 (1.6) 15.1 (1.4) 0.092
Lifetime number of vaginal sex partners, mean (SD) 8.1 (12.3) 8.7 (12.8) 0.652
Self-reported STI history 349 (56.5) 48 (57.8) 0.815
Hormonal contraceptive use at last sex 221 (35.8) 21 (25.3) 0.060
Sexual behaviour in past 90 days
Number of vaginal sex partners, mean (SD) 1.7 (1.8) 1.7 (1.3) 0.997
Percent condom use 49.2 (36.9)∫ 39.1 (38.2)∞ 0.023
Consistently used condoms 102 (17.4)∫ 11 (14.1)∞ 0.466
Drunk or high during sex 164 (26.5) 33 (39.8) 0.012
Psychosocial constructs related to sexual risk behaviour
Stress, mean (SD) 28.2 (13.1) 29.8 (13.6) 0.303
Elevated depressive symptoms 215 (35.0) 37 (44.6) 0.081
Fear of condom negotiation, mean (SD) 8.3 (3.3) 8.2 (2.6) 0.797
Partner communication self-efficacy, mean (SD) 20.5 (3.5) 20.7 (3.8) 0.763
Impulsivity, mean (SD) 38.8 (7.3) 38.0 (9.5) 0.342
Sexual sensation-seeking, mean (SD) 19.2 (4.3) 19.3 (4.5) 0.850
Partner-level factors
Current boyfriend 488 (79.0) 69 (83.1) 0.377
Boyfriend had sex with someone else during relationship 124 (27.5)‡ 15 (25.0)§ 0.683
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Variable
At least one post-intervention
assessment (n=618)
Baseline assessment only (n=83)
p-value
n (%)
Current casual partner 214 (34.6) 28 (33.7) 0.872
Partners generally 2 or more years older 391 (63.3) 55 (66.3) 0.594
Partner recently released from incarceration 96 (15.5) 12 (14.5) 0.799
Partner drunk or high during sex in past 90 days 274 (44.3) 41 (49.4) 0.384
History of abuse
Emotional 346 (56.0) 46 (55.4) 0.922
Physical 243 (39.3) 33 (39.8) 0.939
Sexual 138 (22.3) 30 (36.1) 0.006
∫
n=586 (missing 32 responses)
‡
n=451 (missing 37 responses)
∞
n=78 (missing 5 responses)
§
n=60 (missing 9 responses)
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